Regular support provided by dermatological nurses improves outcomes in patients with psoriasis treated with topical drugs: a randomized controlled trial

被引:5
|
作者
Svendsen, Mathias Tiedemann [1 ,2 ,3 ,4 ]
Feldman, Steven R. [1 ,2 ,3 ,5 ]
Mejldal, Anna [4 ]
Moller, Soren [1 ,4 ]
Kongstad, Line Planck [6 ]
Andersen, Klaus E. [1 ]
机构
[1] Univ Southern Denmark, Dept Clin Res, JB Winslows Vej 19,3, DK-5000 Odense C, Denmark
[2] Odense Univ Hosp, Dept Dermatol, Odense, Denmark
[3] Odense Univ Hosp, Allergy Ctr, Odense, Denmark
[4] Odense Univ Hosp, Open Patient Data Exploratory Network OPEN, Odense, Denmark
[5] Wake Forest Sch Med, Dept Dermatol, Winston Salem, NC 27101 USA
[6] Univ Southern Denmark, Danish Ctr Hlth Econ DaCHE, Odense, Denmark
关键词
PHYSICIANS GLOBAL ASSESSMENT; PLAQUE PSORIASIS; MEDICAL ADHERENCE; SEVERITY INDEX; THERAPY; DISEASE; CARE; CORTICOSTEROIDS; TACHYPHYLAXIS; INTERVENTION;
D O I
10.1111/ced.15370
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Patient adherence to topical antipsoriatic drugs is often poor, leading to poor efficacy. Use of long-term support delivered by dermatological nurses to patients treated with topical drugs may improve outcome. Aim To evaluate whether regular support from dermatological nurses improves outcome and treatment adherence in patients with psoriasis receiving topical medications. Methods We conducted a randomized controlled trial (RCT) ( registration NCT04220554), in which patients received once-daily topical medications (containing corticosteroids and/or calcipotriol) for as long as their psoriasis was visible. The patients were randomly allocated to standard care by the dermatologist either with (n = 51) or without (n = 52) support from dermatological nurses. The nurse support intervention consisted of a structured dermatological consultation at baseline and Week 1, followed by contact with a nurse each month (in the outpatient clinic or by telephone). The primary outcome was severity of psoriasis, which was measured by the Lattice System Physician's Global Assessment (LS-PGA) and assessed by intention-to-treat analyses using linear mixed regression models for longitudinal data. Secondary outcomes were quality of life (measured by the Dermatology Life Quality Index; DLQI) and good adherence (defined as use of >= 80% of recommended doses). Results In total, 92 patients (89%) completed the 48-week trial period. The intervention group improved more than the nonintervention group from baseline to Week 24 in LS-PGA (2.21 vs. 1.28, P = 0.001) and in DLQI at Week 12 (6.50 vs. 1.55, P < 0.001). Differences between the two groups in favour of the intervention were observed throughout the study period. More participants in the intervention group had good adherence compared with the nonintervention group (36% vs. 14%, P < 0.001). Conclusion Regular, continued patient support from dermatological nurses increased the efficacy of psoriasis treatment, improved quality of life and enhanced long-term adherence to topical antipsoriatic drugs. However, there is still room for more improvement.
引用
收藏
页码:2208 / 2221
页数:14
相关论文
共 28 条
  • [21] Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial
    Pronzato, Paolo
    Cortesi, Enrico
    Van der Rut, Carin C.
    Bols, Alain
    Moreno-Nogueira, Jose A.
    de Oliveira, Carlos Freire
    Barrett-Lee, Peter
    Ostler, Peter J.
    Rosso, Ricardo
    ONCOLOGIST, 2010, 15 (09) : 935 - 943
  • [22] Quality-of-life outcomes following topical melatonin application against acute radiation dermatitis in patients with early breast cancer: A double-blind, randomized, placebo-controlled trial
    Zetner, Dennis
    Kamby, Claus
    Gulen, Sengul
    Christophersen, Camilla
    Paulsen, Cecilie B.
    Piga, Emily
    Hoffmeyer, Bodil
    Mahmood, Faisal
    Rosenberg, Jacob
    JOURNAL OF PINEAL RESEARCH, 2023, 74 (01)
  • [23] Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial
    Plechschmidt, Johannes
    Fietkau, Konstantin
    Hepp, Tobias
    Dietrich, Peter
    Fischer, Sarah
    Krebs, Sabine
    Neurath, Markus F.
    Doerje, Frank
    Atreya, Raja
    INFLAMMATORY BOWEL DISEASES, 2024, 31 (01) : 77 - 86
  • [24] Energy-restricted, n-3 polyunsaturated fatty acids-rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: a randomized control clinical trial
    Guida, Bruna
    Napoleone, Anna
    Trio, Rossella
    Nastasi, Annamaria
    Balato, Nicola
    Laccetti, Roberta
    Cataldi, Mauro
    CLINICAL NUTRITION, 2014, 33 (03) : 399 - 405
  • [25] Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial
    Langley, Richard G.
    Feldman, Steven R.
    Han, Chenglong
    Schenkel, Brad
    Szapary, Philippe
    Hsu, Ming-Chun
    Ortonne, Jean-Paul
    Gordon, Kenneth B.
    Kimball, Alexa B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (03) : 457 - 465
  • [26] Patient-Reported Outcomes and the Association With Clinical Response in Patients With Active Psoriatic Arthritis Treated With Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Kavanaugh, Arthur
    McInnes, Iain B.
    Krueger, Gerald G.
    Gladman, Dafna
    Beutler, Anna
    Gathany, Tim
    Mack, Michael
    Tandon, Neeta
    Han, Chenglong
    Mease, Philip
    ARTHRITIS CARE & RESEARCH, 2013, 65 (10) : 1666 - 1673
  • [27] Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial
    Sun, Hongfu
    Li, Minghao
    Huang, Wei
    Zhang, Jian
    Wei, Shihong
    Yang, Yongjing
    Wang, Zhongtang
    Ye, Shucheng
    Gong, Heyi
    Zhang, Yaowen
    Li, Jie
    Song, Haixia
    Wang, Lifang
    Chen, Xiangming
    Lin, Haiqun
    Ding, Gaofeng
    Li, Hongwei
    Zheng, Anping
    Ma, Xuezhen
    Chen, Shaoshui
    Liu, Liping
    Zhang, Kaixian
    Fu, Chengrui
    Liu, Wenzhi
    Wang, Jing
    Zhang, Xiaqin
    Liu, Tingting
    Han, Dan
    Zhao, Qian
    Wu, Peipei
    Yuan, Qianqian
    Tian, Lijun
    Zhang, Ping
    Wu, Xueqin
    Chen, Fei
    Zhang, Zicheng
    Li, Baosheng
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (04) : 412 - 421
  • [28] Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial
    Strand, Vibeke
    Mease, Philip
    Burmester, Gerd R.
    Nikai, Enkeleida
    Coteur, Geoffroy
    van Vollenhoven, Ronald
    Combe, Bernard
    Keystone, Edward C.
    Kavanaugh, Arthur
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (06)